Mays Cancer Center Annual Report Magazine

2022 issue
Robert Hromas, MD, Dean, Joe R. and Teresa Lozano Long School of Medicine and Vice President for Medical Affairs, UT Health San Antonio

A year of transformative progress

UT Health San Antonio's Joe R. and Teresa Lozano Long School of Medicine Dean Robert Hromas, MD, identifies four areas of focus of the Mays Cancer Center in its quest to end cancer for communities in South Texas and beyond.
Sandeep Burma, PhD, Professor of Neurosurgery and Biochemistry and Structural Biology; Mays Family Foundation Distinguished Chair in Oncology; Vice Chair for Research, Department of Neurosurgery

The biology of cancer

Mays Cancer Center researchers are making significant strides in understanding risk factors and conditions that cause cancers to develop and progress and assessing impacts on the health and recovery of patients with cancer.
Ratna Vadlamudi, PhD, Professor and Vice Chair for Research, Department of Obstetrics and Gynecology

Promising compound kills range of hard-to-treat cancers

Ratna Vadlamudi, PhD, a professor of obstetrics and gynecology at the Mays Cancer Center, is researching compounds that can target cancer cells to stop their growth.
Mosaic image of hands touching

New discoveries in pediatric cancer research

The findings from recent research studies in pediatric cancer offer hope for drug development.
Mosaic art

Disparities discussed at San Antonio Breast Cancer Symposium

Researchers from the Mays Cancer Center at UT Health San Antonio presented results of multiple lines of study during the San Antonio Breast Cancer Symposium, operated in conjunction with the American Association of Cancer Research.
Researcher in lab

How COVID-19 vaccines affect patients with cancer

Mays Cancer Center researchers are studying how the immune system responds to the novel coronavirus vaccine in patients with cancer, and why many Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.
Sukeshi Patel Arora, MD, Associate Professor; Leader of Gastrointestinal Oncology Program

The science of cancer

The Mays Cancer Center is advancing cancer care and awareness among diverse populations, increasing their participation in cancer research, leading the conversation about the need for health equity and pursuing partnerships and alliances to increase diversity in clinical trials.
Mays Cancer Center physician with patient

Boosting Hispanic representation in cancer research

The Mays Cancer Center has been named a founding partner of the Advancing Inclusive Research Site Alliance, a coalition of clinical research sites seeking to advance the representation of diverse patient populations in clinical trials.
Mays Cancer Center patient Rainee Miller, left, pictured with first lady Jill Biden.

First lady Jill Biden visits Mays Cancer Center

In February 2022, first lady Jill Biden toured the Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Hispanics.
Marcela Mazo Canola, MD, Assistant Professor, Department of Breast Oncology

The intersection of research and practice

The Mays Cancer Center is testing new treatments to enhance and extend the life of patients with cancer and translating leading-edge research into new drugs and technology-assisted procedures that are improving patient health and recovery.
UT Health San Antonio researchers conduct biopharmaceutical studies

NIH grant to boost ovarian cancer drug development

The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.
A surgeon performs a robotic surgery.

Exploring technological advances in patient treatment

Mays Cancer Center is at the forefront of technology-assisted surgical treatments that are improving patient recovery.
1 2